Gene: SEMA4C
Official Full Name: semaphorin 4Cprovided by HGNC
Gene Summary: Predicted to enable chemorepellent activity; neuropilin binding activity; and semaphorin receptor binding activity. Involved in muscle cell differentiation and positive regulation of stress-activated MAPK cascade. Located in extracellular space. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14226 | SEMA4C Knockout cell line (HeLa) | Human | SEMA4C | 1:3~1:6 | Negative | Online Inquiry |
KO14227 | SEMA4C Knockout cell line (HCT 116) | Human | SEMA4C | 1:2~1:4 | Negative | Online Inquiry |
KO14228 | SEMA4C Knockout cell line (HEK293) | Human | SEMA4C | 1:3~1:6 | Negative | Online Inquiry |
KO14229 | SEMA4C Knockout cell line (A549) | Human | SEMA4C | 1:3~1:4 | Negative | Online Inquiry |
SEMA4C Gene Knockout Cell Lines are specifically engineered cell lines that have undergone targeted gene editing to deactivate the SEMA4C gene, which encodes for a member of the semaphorin family known to play a critical role in cellular signaling and immune responses. The knockout of SEMA4C enables researchers to study the resulting phenotypic changes, providing vital insights into its contributions to various biological processes, including neuronal development, axon guidance, and immune system regulation.
These cell lines leverage the CRISPR-Cas9 gene-editing technology, which allows for precise and efficient disruption of the SEMA4C gene. By knocking out this specific gene, researchers can investigate the mechanistic pathways involved in SEMA4C-related activities and its potential implication in pathological conditions such as cancer and autoimmune diseases. Additionally, SEMA4C knockout models serve as invaluable tools for drug discovery and development, as they allow for the assessment of therapeutic targets related to immune modulation.
The scientific importance of SEMA4C Gene Knockout Cell Lines is underscored by their applicability in both fundamental research and clinical settings. They facilitate the exploration of novel therapeutics aimed at modulating immune responses or pathfinding in neuronal cells, making them especially relevant for neuropathologies and oncological studies. Compared to alternative products, our SEMA4C knockout cell lines offer unmatched specificity and reliability, ensuring that researchers can trust the accuracy of their findings.
Researchers and clinicians will find significant value in utilizing SEMA4C Gene Knockout Cell Lines not only for their experimental robustness but also for their potential to enhance our understanding of intricate biological mechanisms and drive innovation in therapeutic interventions. Backed by our company’s extensive expertise in genetic engineering and commitment to advancing biological research, we provide high-quality cell lines that meet the rigorous standards required for contemporary scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.